Clinical Trials Browser

LHRH, lysine(6)-doxorubicin × Genitourinary × Clear all

NCT01234519 2018-03-15

A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy

Phase 1/2 Terminated

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

NCT01240629 2017-07-11

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms